Skip to main content
Clinical Trials/IRCT20210630051751N1
IRCT20210630051751N1RecruitingPhase 3

Evaluation of the effect of vitamin D supplementation on insulin resistance, lipid profile, thyroid function indices and body composition in overweight and obese patients with hypothyroidism and glucose intolerance

Shiraz University of Medical Sciences0 sites50 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 75 years (—)
Sex
All

Inclusion Criteria

  • Individuals between 20 and 75 years old.
  • Overweight or obese individuals with a body mass index above 25.
  • Individuals Suffering from hypothyroidism with TSH levels higher than 7 microIU/ml.
  • Individuals with impaired glucose tolerance with fasting plasma glucose levels above 100 mg/dL or 2-hour plasma glucose above 140 mg / dL.
  • Individuals with serum 25-hydroxyvitamin D3 concentration is less than 30 ng/ml.

Exclusion Criteria

  • Individuals with cancer, kidney, liver, cardiovascular, bone, and endocrine diseases other than hypothyroidism and glucose intolerance disorders.
  • Individuals taking drugs related to diseases such as cancer, kidney, liver, heart, and drugs that affect bone metabolism (estrogen, selective estrogen receptor modulator, bisphosphonate, vitamin D, or calcium).
  • Individuals consuming multivitamins-minerals.
  • Pregnant and lactating women.

Investigators

Similar Trials